Lexicon Pharmaceuticals Inc
NASDAQ:LXRX

Watchlist Manager
Lexicon Pharmaceuticals Inc Logo
Lexicon Pharmaceuticals Inc
NASDAQ:LXRX
Watchlist
Price: 1.21 USD -0.82% Market Closed
Market Cap: 439.7m USD

Wall Street
Price Targets

LXRX Price Targets Summary
Lexicon Pharmaceuticals Inc

Wall Street analysts forecast LXRX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for LXRX is 2.94 USD with a low forecast of 1.01 USD and a high forecast of 6.3 USD.

Lowest
Price Target
1.01 USD
17% Downside
Average
Price Target
2.94 USD
143% Upside
Highest
Price Target
6.3 USD
421% Upside
Lexicon Pharmaceuticals Inc Competitors:
Price Targets
9966
Alphamab Oncology
9% Downside
BCYC
Bicycle Therapeutics PLC
201% Upside
MOLN
Molecular Partners AG
178% Upside
TWST
Twist Bioscience Corp
17% Upside
AZT
Arcticzymes Technologies ASA
54% Upside
002007
Hualan Biological Engineering Inc
25% Upside
068270
Celltrion Inc
22% Upside
GOSS
Gossamer Bio Inc
193% Upside

Revenue
Forecast

Revenue Estimate
Lexicon Pharmaceuticals Inc

For the last 13 years the compound annual growth rate for Lexicon Pharmaceuticals Inc's revenue is 25%. The projected CAGR for the next 4 years is 19%.

25%
Past Growth
19%
Estimated Growth
Estimates Accuracy
0%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Lexicon Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-5%
Average Miss

Net Income
Forecast

Net Income Estimate
Lexicon Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-77%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is LXRX's stock price target?
Price Target
2.94 USD

According to Wall Street analysts, the average 1-year price target for LXRX is 2.94 USD with a low forecast of 1.01 USD and a high forecast of 6.3 USD.

What is Lexicon Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
19%

For the last 13 years the compound annual growth rate for Lexicon Pharmaceuticals Inc's revenue is 25%. The projected CAGR for the next 4 years is 19%.

Back to Top